HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kun Ren Selected Research

HDL cholesteryl ester

1/2018MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kun Ren Research Topics

Disease

12Atherosclerosis
10/2021 - 01/2015
8Inflammation (Inflammations)
11/2020 - 05/2017
4Cardiovascular Diseases (Cardiovascular Disease)
10/2021 - 01/2017
4Atherosclerotic Plaque (Atheroma)
12/2020 - 01/2018
3Neoplasms (Cancer)
01/2019 - 11/2014
2Obesity
12/2021 - 01/2015
1Carbuncle
09/2022
1Pain (Aches)
09/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2020
1Hypertension (High Blood Pressure)
01/2020
1Reperfusion Injury
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2019
1Arteritis
12/2018
1Pathologic Processes
11/2018
1Dyslipidemias (Dyslipidemia)
01/2017
1Neointima
01/2017
1Deglutition Disorders (Dysphagia)
09/2016
1Progressive Bulbar Palsy (Fazio Londe Syndrome)
09/2016
1Stroke (Strokes)
09/2016
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
11/2015
1Dementia (Dementias)
11/2015
1Neoplasm Metastasis (Metastasis)
11/2014

Drug/Important Bio-Agent (IBA)

9CholesterolIBA
10/2021 - 01/2017
8LipidsIBA
12/2020 - 01/2017
4Apolipoproteins E (ApoE)IBA
12/2020 - 01/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021 - 11/2015
2Long Noncoding RNAIBA
12/2020 - 11/2020
2HDL CholesterolIBA
12/2019 - 01/2018
1Acetic Acid (Vinegar)FDA LinkGeneric
09/2022
1FrankincenseIBA
09/2022
1Polysaccharides (Glycans)IBA
09/2022
1Volatile Oils (Essential Oils)IBA
09/2022
1AcidsIBA
09/2022
1Antihypertensive Agents (Antihypertensives)IBA
12/2021
1AdiponectinIBA
10/2021
1Proteins (Proteins, Gene)FDA Link
10/2021
1Competitive Endogenous RNAIBA
12/2020
1Pharmaceutical PreparationsIBA
01/2020
1IsoflavonesIBA
01/2020
1RelaxinIBA
01/2020
1Trimetazidine (Vastarel)IBA
01/2020
1VimentinIBA
01/2020
1biochanin AIBA
01/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020
1mangiferinIBA
12/2019
1Triglycerides (Triacylglycerol)IBA
12/2019
1LDL CholesterolIBA
12/2019
1ColchicineFDA LinkGeneric
11/2019
1Glutathione (Reduced Glutathione)IBA
01/2019
1Acetylcysteine (Siran)FDA LinkGeneric
01/2019
1SphingolipidsIBA
11/2018
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
11/2018
1QuercetinIBA
01/2018
1ApigeninIBA
01/2018
1Scavenger Receptors (Scavenger Receptor)IBA
01/2018
1HDL cholesteryl esterIBA
01/2018
1oxidized low density lipoproteinIBA
05/2017
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2017
1Apolipoprotein A-I (Apolipoprotein A1)IBA
05/2017
1Interleukin-10 (Interleukin 10)IBA
05/2017
1ApolipoproteinsIBA
01/2017
1AlkaloidsIBA
01/2017
1Apolipoproteins MIBA
01/2017
1leonurineIBA
01/2017
1Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
01/2017
1FurinIBA
01/2017
1Therapeutic UsesIBA
09/2016
1salicylhydroxamic acid (SHAM)IBA
11/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2015
1Glucose (Dextrose)FDA LinkGeneric
01/2015
1MicroRNAs (MicroRNA)IBA
11/2014

Therapy/Procedure

1Chinese Traditional Medicine (Traditional Chinese Medicine)
09/2022
1Therapeutics
01/2019